COI - Key Personnel

The University is required to maintain a website to ensure public accessibility to the Conflict of Interest (COI) policy.

Furthermore, the University is required to maintain information concerning any significant financial interest disclosed to the University that meets the following three criteria:

  • The significant financial interest was disclosed and is still held by the senior/key personnel
  • The University determines that the significant financial interest is related to funded research or to scholarly and/or educational activities funded under external grants, contracts or cooperative agreements; and
  • The University determines that the significant financial interest is a Financial Conflict of Interest (FCOI).

 

The following personnel have met the above criteria:

Cote, Richard, M.D.
Title/role: Principal Investigator
Name of SFI entity: Filtini, Inc.
Nature of SFI: Equity Ownership; Consultant; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Cote owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Title/role: Principal Investigator
Name of SFI entity: Circulogix
Nature of SFI: Consulting; Board of Directors; equity interest; intellectual property
Approximate Dollar Amount: Dr. Cote owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

 

Webster, Keith, Ph.D.
Title/role: Principal Investigator
Name of SFI entity: Integene International
Nature of SFI: Equity Ownership; Inventor of Intellectual Property; Board of Directors
Approximate Dollar Amount: Dr. Webster owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

 

Harbour, James, M.D.
Title/role: Principal Investigator
Name of SFI entity: Washington University; Castle Biosciences
Nature of SFI: Royalties received as Inventor of Intellectual Property; Consultant
Approximate Dollar Amount: Dr. Harbour received royalties in the amount of $20,000-40,000; compensation from this company in the amount of $10,000-20,000.

 

Levy, Robert, Ph.D.
Title/role: Principal Investigator
Name of SFI entity: Allergan
Nature of SFI: Consultant
Approximate Dollar Amount: Dr. Levy received compensation from this company in the amount of $5,000-9,999.

 

Liddle, Howard, E.D.D.
Title/role: Principal Investigator; Study Team Member
Name of SFI entity: MDFT International
Nature of SFI: Chairman; Board of Directors; Consultant
Approximate Dollar Amount: Dr. Liddle received compensation as salary from this company in the amount of $5,000-9,999. Dr. Liddle's spouse, Dr. Dakof, also has a professional relationship with this company. She received between $20,000-100,000 as the Director of MDFT International.

 

Hare, Joshua, M.D.
Title/role: Principal Investigator
Name of SFI entity: Vestion
Nature of SFI: Equity Ownership
Approximate Dollar Amount: Dr. Hare owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value. In addition, Dr. Hare has received compensation in the amount of $20,000 - $100,000.
Title/role: Principal Investigator
Name of SFI entity: Biscayne Pharmaceuticals
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Hare owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Title/role: Principal Investigator
Name of SFI entity: Longeveron, LLC
Nature of SFI: Equity Ownership; Chief Scientific Officer
Approximate Dollar Amount: Dr. Hare owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value. In addition, Dr. Hare has received compensation in the amount of $250,000 - $299,999
Ricordi, Camillo, M.D.
Title/role: Team Member
Name of SFI entity: Ophysio, Inc
Nature of SFI: Equity Ownership; Inventor of Intellectual Property; Advisory Board
Approximate Dollar Amount: Dr. Ricordi owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

 

Alejandro, Rodolfo, M.D.
Title/role: Principal Investigator
Name of SFI entity: Converge
Nature of SFI: Equity Ownership
Approximate Dollar Amount: Dr. Alejandro owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

  

Pileggi, Antonello, M.D., Ph.D.
Title/role: Principal Investigator
Name of SFI entity: Converge Biotech
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Pileggi owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

  

Dakof, Gayle, Ph.D.
Title/role: Co-Investigator
Name of SFI entity: MDFT International
Nature of SFI: Director
Approximate Dollar Amount: Dr. Dakof received compensation as salary and travel from this company in the amount of $20,000-100,000. Dr. Dakof's spouse, Dr. Liddle, also has a professional relationship with this company. He received between $5,000-9,999 as the Chairman, Board of Directors, and consultant for MDT International.
 Gustafson, David, Ph.D.
Title/role: Sub-Contractor
Name of SFI entity: D. Gustafson & Associates
Nature of SFI: Sole Ownership; Consultant
Approximate Dollar Amount: Dr. Gustafson received compensation as salary from this company in the amount of $20,000-100,000. He is also a consultant for this company.

 

Capobianco, Anthony, Ph.D.
Title/role: Principal Investigator; Study Team Member
Name of SFI entity: StemSynergy Therapeutics, Inc.
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Capobianco owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

 

Goldberger, Jeffrey, M.D.
Title/role: Team Member
Name of SFI entity: Gold-T Tech, Inc.
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Goldberger owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

 

Jy, Wenche, Ph.D.
Title/role: Team Member
Name of SFI entity: RxMP Therapeutics, LLC
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Jy owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

 

Ahn, Yeon , M.D.
Title/role: Team Member
Name of SFI entity: RxMP Therapeutics, LLC
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Ahn owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

 

Dietrich, Dalton, Ph.D.
Title/role: Principal Investigator
Name of SFI entity: InflamaCORE, LLC
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Dietrich owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

 

de Rivero Vaccari, Juan Pablo, Ph.D.
Title/role: Team Member
Name of SFI entity: InflamaCORE, LLC
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. de Rivero Vaccari owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.

 

Keane, Robert, Ph.D.
Title/role: Team Member
Name of SFI entity: InflamaCORE, LLC
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Keane owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Knighton, Robert, M.D.
Title/role: Team Member
Name of SFI entity: Carl Zeiss Meditec
Nature of SFI: Consultant
Approximate Dollar Amount: Dr. Knighton has received compensation from this company in the amount of $10,000-$20,000.
Saluja, Ashok, Ph.D.
Title/role: Principal Investigator
Name of SFI entity: Minneamrita Therapeutics
Nature of SFI: Equity; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Saluja owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Banerjee, Sulagna, Ph.D.
Title/role: Principal Investigator and Team Member
Name of SFI entity: Minneamrita Therapeutics
Nature of SFI: Consultant
Approximate Dollar Amount: Dr. Banerjee has received compensation from this company in the amount of $10,000-$20,000.
Franzmann, Elizabeth, M.D.
Title/role: Team Member
Name of SFI entity: Vigilant Biosciences
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Franzmann owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Fraker, Christopher, Ph.D.
Title/role: Principle Investigator and Team Member
Name of SFI entity: Ophysio, Inc
Nature of SFI: Principal Investigator and Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Fraker owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Dominguez-Bendala, Juan, Ph.D.
Title/role: Principal Investigator
Name of SFI entity: Ophysio, Inc
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Dominguez-Bendala owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Tomei, Alice, Ph.D.
Title/role: Team Member
Name of SFI entity: Converge, Biotech
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Tomei owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Dhar, Shanta, Ph.D.
Title/role: Principal Investigator
Name of SFI entity: Partikula LLC
Nature of SFI: Consultant; Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Dhar has received compensation in the amount of $20,000 - $100,000 from this company. In addition, Dr. Dhar owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Züchner, Stephan, M.D.
Title/role: Principal Investigator
Name of SFI entity: ViaGenetics, LLC
Nature of SFI: Equity Ownership; Board of Directors
Approximate Dollar Amount: Dr. Dr. Züchner owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Schüle, Rebecca, M.D.
Title/role: Principal Investigator
Name of SFI entity: ViaGenetics, LLC
Nature of SFI: Consultant
Approximate Dollar Amount: Dr. Schüle has received compensation in the amount of $0 - $10,000 from this company.
Harvey, Philip, Ph.D.
Title/role: Team Member
Name of SFI entity: i-Function, Inc.
Nature of SFI: Equity Ownership; Chief Scientific Officer
Approximate Dollar Amount: Dr. Harvey owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Czaja, Sara, Ph.D.
Title/role: Principal Investigator/Team Member
Name of SFI entity: i-Function, Inc.
Nature of SFI: Equity Ownership/Compensation
Approximate Dollar Amount: Dr. Czaja owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Kasahara, Noriyuki, M.D., Ph.D.
Title/role: Principal Investigator
Name of SFI entity: Tocagen, Inc.
Nature of SFI: Equity Ownership
Approximate Dollar Amount: Dr. Kasahara owns equity in this company, in the amount of $700,000-$749,999.
Robbins, David, Ph.D.
Title/role: Principal Investigator/Team Member
Name of SFI entity: StemSynergy Therapeutics
Nature of SFI: Equity Ownership
Approximate Dollar Amount: Dr. Robbins owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
 Shousha, Mohammad Abou, M.D.
Title/role: Principal Investigator
Name of SFI entity: Resolve Ophthalmics, LLC
Nature of SFI: Equity Ownership
Approximate Dollar Amount: Dr. Abou Shousha owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Yoo, Sonia, M.D.
Title/role: Team Member
Name of SFI entity: Resolve Ophthalmics, LLC
Nature of SFI: Equity Ownership
Approximate Dollar Amount: Dr. Yoo owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Alvarez, Ofelia, M.D.
Title/role: Team Member
Name of SFI entity: Novartis
Nature of SFI: Consultant
Approximate Dollar Amount: Dr. Alvarez has received compensation from this company in the amount of $5,000-$9,999.
McCarthy, Micheline, M.D.
Title/role: Team Member
Name of SFI entity: Novartis
Nature of SFI: Consultant and Advisory Board Member
Approximate Dollar Amount: Dr. McCarthy has received compensation from this company in the amount of $5,000-$9,999.
 Rammohan, Kottil, M.D.
Title/role: Team Member
Name of SFI entity: Novartis
Nature of SFI: Consultant and Advisory Board Member
Approximate Dollar Amount: Dr. Rammohan has received compensation from this company in the amount of $5,000-$9,999.
Title/role: Team Member
Name of SFI entity: Genzyme
Nature of SFI: Consultant and Advisory Board Member
Approximate Dollar Amount: Dr. Rammohan has received compensation from this company in the amount of $5,000-$9,999.
Mahtani, Reshma, D.O.
Title/role: Team Member
Name of SFI entity: Novartis
Nature of SFI: Consultant and Advisory Board Member
Approximate Dollar Amount: Dr. Mahtani has received compensation from this company in the amount of $10,000-24,999.
Title/role: Team Member
Name of SFI entity: AstraZeneca
Nature of SFI: Consultant and Advisory Board Member
Approximate Dollar Amount: Dr. Mahtani has received compensation from this company in the amount of $5,000-9,999.
Title/role: Team Member
Name of SFI entity: Pfizer
Nature of SFI: Consultant and Advisory Board Member
Approximate Dollar Amount: Dr. Mahtani has received compensation from this company in the amount of $10,000-24,999.
Benedetto, Pasquale, M.D.
Title/role: Team Member
Name of SFI entity: Novartis
Nature of SFI: Consultant and Advisory Board Member
Approximate Dollar Amount: Dr. Benedetto has received compensation from this company in the amount of $5,000-$9,999.
Rawal, Siddarth, M.D.
Title/role: Team Member
Name of SFI entity: Circulogix
Nature of SFI: Consulting; Board of Directors; equity interest; intellectual property
Approximate Dollar Amount: Dr. Rawal owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Davis, Janet, M.D.
Title/role: Principal Investigator
Name of SFI entity: Allergan
Nature of SFI: Consulting; Advisory Board
Approximate Dollar Amount: Dr. Davis received compensation from this company in the amount of $5,000-9,999.
Ehrenreich-May, Jill, Ph.D.
Title/role: Principal Investigator
Name of SFI entity: Kinark Child and Family Services
Nature of SFI: Teaching, training, Lecturing or speaking; Sponsored or reimbursed travel
Approximate Dollar Amount: Dr. Ehrenreich-May received compensation from this company in the amount of $10,000-$19,999.
Alencar, Alvaro, M.D.
Title/role: Team Member
Name of SFI entity: Genetech
Nature of SFI: consultant and scientific advisory board member
Approximate Dollar Amount: Dr. Alencar received compensation from this company in the amount of $20,000-$100,000.
Slomovitz, Brain, M.D.
Title/role: Team Member
Name of SFI entity: Genetech
Nature of SFI: consultant and scientific advisory board member
Approximate Dollar Amount: Dr. Slomovitz received compensation from this company in the amount of $5,000-$9,999.
 Li, Wei, Ph.D.
Title/role: Principal Investigator
Name of SFI entity: Everglades Biopharma
Nature of SFI: Equity Ownership; Inventor of Intellectual Property
Approximate Dollar Amount: Dr. Li owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Tian, Hong, Ph.D.
Title/role: Principal Investigator
Name of SFI entity: Everglades Biopharma
Nature of SFI: Equity Ownership
Approximate Dollar Amount: Dr. Tian owns equity in this private company, the value of this interest cannot be readily determined through reference to public prices or other reasonable measures of fair market value.
Dobliecki-Lewis, Suzanne, M.D. 
Title/role: Team member
Name of SFI entity: Gilead Pharmaceuticals
Nature of SFI: Consultant
Approximate Dollar Amount: Dr. Dobliecki-Lewis has received compensation in the amount of $0 - $10,000 from this company.
James Hoffman, M.D.
Title/role: Principal Investigator
Name of SFI entity: Celgene
Nature of SFI: consultant or scientific advisory board member and teaching, training, lecturing or speaking
Approximate Dollar Amount: Dr. Hoffman received compensation from this company in the amount of $20,000-$100,000.
SFI - Significant Financial Interest

The information provided is current as of 6/04/19 and is subject to updates, on at least an annual basis and within 60 days of the Institution’s identification of a new FCOI.